"Better to ask rich countries for money. For finance, to put more capacity in and to do new trials to get more out of existing vaccines, and to find, COVAX, for the most vulnerable and health workers in low-income countries," says Michael Kremer, winner of Nobel prize 2019 on global inequality in distribution of vaccines.